Reviva Pharmaceuticals Holdings, Inc.
RVPHNASDAQ
Healthcare
Biotechnology
$0.70
-0.01(-2.1%)
52W $0.66 – $22.40
Quick:
SCHEDULE 13G
Mar 30, 2026 (1 weeks ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Mar 30, 2026 (1 weeks ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G
Mar 25, 2026 (1 weeks ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Mar 19, 2026 (2 weeks ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Mar 5, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Feb 17, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Jan 23, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Jan 16, 2026 (2 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Dec 23, 2025 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13D/A
Dec 22, 2025 (3 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
8-K
Nov 13, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Nov 13, 2025 (4 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Oct 17, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G
Sep 29, 2025 (6 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Sep 26, 2025 (6 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13D/A
Sep 24, 2025 (6 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
SCHEDULE 13D/A
Sep 24, 2025 (6 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
8-K
Sep 19, 2025 (6 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Aug 14, 2025 (7 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Aug 14, 2025 (7 months ago)Current Report
Material event disclosure
Event materiality and market reaction